{"id":238,"date":"2010-07-22T17:54:05","date_gmt":"2010-07-22T21:54:05","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=238"},"modified":"2010-07-22T17:54:05","modified_gmt":"2010-07-22T21:54:05","slug":"financing-deals-22-july-2010","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=238","title":{"rendered":"Financing Deals: 22 July 2010"},"content":{"rendered":"<p><a href=\"http:\/\/www.axiomed.com\">AxioMed Spine Corporation<\/a>, a spinal orthopedics company developing products to restore spinal function in patients with degenerative spine disease, announced today that it has raised $14.5 million in two tranches from both current and new investors, not identified by the company. The funding will provide AxioMed with the ability to complete a study in the US of its lumbar disc, get approval for its cervical disc product, and start or expand sales of both products in Europe.<\/p>\n<p><a href=\"http:\/\/www.intlstemcell.com\">International Stem Cell Corporation<\/a>, an Oceanside, California biotechnology company focused on therapeutic and research products, announced today an agreement with ARG Vermogensverwaltung AG (ARG), a German investment fund, to create a new European subsidiary, called ISCO Europe, to be funded with up to $10 million of capital derived from ARG and other independent sources in Europe. The new subsidiary is expected to be funded by a private equity investment by ARG and that ARG will then assist in forming an investment group to invest up to $10 million concurrently with the listing of ISCO Europe on the Deutsche Bourse.<\/p>\n<p><a href=\"http:\/\/www.euthymics.com\/\">Euthymics Bioscience Inc.<\/a>, in Cambridge, Massachusetts, a clinical-stage company developing antidepressants, today announced the completion of additional Series A (first-round after seed capital) financing. This round, led by Novartis Venture Funds and Venture Investors, provides a total investment commitment of $24 million in milestone-conditioned tranches. Hambrecht &amp; Quist Capital Management, LLC, GBS Venture Partners, and the State of Wisconsin Investment Board also participated in the financing. The first Series A proceeds were used to complete the acquisition of DOV Pharmaceutical, Inc. and allow for the continued development of DOV\u2019s unique antidepressant, EB-1010.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AxioMed Spine Corporation, a spinal orthopedics company developing products to restore spinal function in patients with degenerative spine disease, announced today that it has raised $14.5 million in two tranches from both current and new investors, not identified by the company. The funding will provide AxioMed with the ability to complete a study in the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[31,28,23,48],"class_list":["post-238","post","type-post","status-publish","format-standard","hentry","category-finance","tag-biomedical","tag-clinical-trials","tag-equity","tag-stem-cells"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=238"}],"version-history":[{"count":2,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/238\/revisions"}],"predecessor-version":[{"id":240,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/238\/revisions\/240"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}